Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-12-000368

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jun 30, 2012 82.33M sh
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$5.95M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$81.97K
Long Term Debt Q2 2012 · Jun 30, 2012 $303.33K
Long Term Debt Q2 2012 · Dec 31, 2011 $196.83K
Current Liabilities Q2 2012 · Jun 30, 2012 $889.04K
Current Liabilities Q2 2012 · Dec 31, 2011 $1.08M
Current Assets Q2 2012 · Jun 30, 2012 $22.63K
Current Assets Q2 2012 · Dec 31, 2011 $8.68K
Total Assets Q2 2012 · Jun 30, 2012 $45.52K
Total Assets Q2 2012 · Dec 31, 2011 $39.41K
Sga Expense Q2 2012 · Jun 30, 2012 $2.56M
Sga Expense Q2 2012 · Jun 30, 2011 $17.78K
Sga Expense Q2 2012 · Jun 30, 2011 $34.23K
Rd Expense Q2 2012 · Jun 30, 2012 $1.3M
Net Income Q2 2012 · Jun 30, 2012 −$13.01M
Net Income Q2 2012 · Jun 30, 2011 −$109.54K